Long-term survival and complications of Fontan patients: where do we stand?

IF 1.3
American journal of cardiovascular disease Pub Date : 2026-02-15 eCollection Date: 2026-01-01 DOI:10.62347/IHTH5044
Adam Najm, Fayez Yassine, Assyl Amhaz, Fadi Bitar, Mariam Arabi
{"title":"Long-term survival and complications of Fontan patients: where do we stand?","authors":"Adam Najm, Fayez Yassine, Assyl Amhaz, Fadi Bitar, Mariam Arabi","doi":"10.62347/IHTH5044","DOIUrl":null,"url":null,"abstract":"<p><p>Single ventricle disease (SVD) is a rare but severe form of congenital heart disease (CHD) which requires surgical palliation through the Fontan procedure. This operation, which was pioneered in 1971, has become the final part of a surgical pathway after the Norwood and Glenn procedures. The pathway aims to reduce the load on the functional ventricle whilst improving systemic blood oxygenation. Advances in surgical technique and the modern era have shifted the approach from addressing mortality concerns to offering a lifeline to patients in need. With improved survival, the Fontan population grows which requires an emphasis on the lifelong complications that these individuals face along with specific risk factors that predispose them to these issues allowing for risk stratification and systematic monitoring. This narrative review aims to summarize the recent cohort studies on Fontan patients to identify long-term outcomes of the procedure along with their associated risk factors. The literature review was conducted till December 2025 using PubMed, Scopus, and Google Scholar, the procedure itself is not curative. I has numerous morbidities including arrhythmia, heart failure, neurocognitive delays, protein-losing enteropathy, renal dysfunction, and Fontan-associated liver disease (FALD). FALD specifically may affect over half of Fontan patients within 35 years and the seriousness of FALD sequelae including cirrhosis and hepatocellular carcinoma underscores the need to prioritize early and systematic monitoring. Preoperatively, demographic, surgical, and biomarker risk factors have been shown to be predictors of postoperative complications/mortality. Overall, Fontan patients tend to have excellent survival rates over both the short and long terms compared to prior surgical eras. As postoperative concerns now shift from early mortality to long-term complications, our healthcare system must adapt to ensure lifelong follow-up and a systematic approach for early detection.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"16 1","pages":"30-49"},"PeriodicalIF":1.3000,"publicationDate":"2026-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13003216/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cardiovascular disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62347/IHTH5044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Single ventricle disease (SVD) is a rare but severe form of congenital heart disease (CHD) which requires surgical palliation through the Fontan procedure. This operation, which was pioneered in 1971, has become the final part of a surgical pathway after the Norwood and Glenn procedures. The pathway aims to reduce the load on the functional ventricle whilst improving systemic blood oxygenation. Advances in surgical technique and the modern era have shifted the approach from addressing mortality concerns to offering a lifeline to patients in need. With improved survival, the Fontan population grows which requires an emphasis on the lifelong complications that these individuals face along with specific risk factors that predispose them to these issues allowing for risk stratification and systematic monitoring. This narrative review aims to summarize the recent cohort studies on Fontan patients to identify long-term outcomes of the procedure along with their associated risk factors. The literature review was conducted till December 2025 using PubMed, Scopus, and Google Scholar, the procedure itself is not curative. I has numerous morbidities including arrhythmia, heart failure, neurocognitive delays, protein-losing enteropathy, renal dysfunction, and Fontan-associated liver disease (FALD). FALD specifically may affect over half of Fontan patients within 35 years and the seriousness of FALD sequelae including cirrhosis and hepatocellular carcinoma underscores the need to prioritize early and systematic monitoring. Preoperatively, demographic, surgical, and biomarker risk factors have been shown to be predictors of postoperative complications/mortality. Overall, Fontan patients tend to have excellent survival rates over both the short and long terms compared to prior surgical eras. As postoperative concerns now shift from early mortality to long-term complications, our healthcare system must adapt to ensure lifelong follow-up and a systematic approach for early detection.

Fontan患者的长期生存和并发症:我们站在哪里?
单心室疾病(SVD)是一种罕见但严重的先天性心脏病(CHD),需要通过Fontan手术来缓解。这种手术始于1971年,是诺伍德和格伦手术之后的最后一种手术方式。该途径旨在减少功能性心室的负荷,同时改善全身血液氧合。外科技术和现代时代的进步已经将解决死亡率问题的方法转变为为有需要的患者提供生命线。随着生存率的提高,Fontan人口的增长需要强调这些个体面临的终身并发症以及使他们易患这些问题的特定风险因素,从而允许风险分层和系统监测。这篇叙述性综述旨在总结最近关于Fontan患者的队列研究,以确定手术的长期结果及其相关的危险因素。截至2025年12月,使用PubMed、Scopus和b谷歌Scholar进行文献综述,手术本身并不能治愈。I有多种发病率,包括心律失常、心力衰竭、神经认知延迟、蛋白质丢失性肠病、肾功能障碍和丰坦相关肝病(FALD)。FALD可能在35年内影响超过一半的Fontan患者,FALD后遗症(包括肝硬化和肝细胞癌)的严重性强调了优先进行早期和系统监测的必要性。术前、人口统计学、手术和生物标志物危险因素已被证明是术后并发症/死亡率的预测因素。总的来说,与以前的手术时代相比,Fontan患者的短期和长期生存率都很好。随着术后关注从早期死亡转向长期并发症,我们的医疗保健系统必须适应确保终身随访和系统的早期发现方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of cardiovascular disease
American journal of cardiovascular disease CARDIAC & CARDIOVASCULAR SYSTEMS-
自引率
0.00%
发文量
21
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书